Molecular Pharmacology: 42 (4)

October 01, 1992; Volume 42,Issue 4

You have access
Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.
J D Kursar, D L Nelson, D B Wainscott, M L Cohen and M Baez

Molecular Pharmacology October 1992, 42 (4) 549-557;
You have access
Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent.
R F Kletzien, L A Foellmi, P K Harris, B M Wyse and S D Clarke

Molecular Pharmacology October 1992, 42 (4) 558-562;
You have access
Cloning and expression of a high affinity taurine transporter from rat brain.
K E Smith, L A Borden, C H Wang, P R Hartig, T A Branchek and R L Weinshank

Molecular Pharmacology October 1992, 42 (4) 563-569;
You have access
Class I and IV antiarrhythmic drugs and cytosolic calcium regulate mRNA encoding the sodium channel alpha subunit in rat cardiac muscle.
H J Duff, J Offord, J West and W A Catterall

Molecular Pharmacology October 1992, 42 (4) 570-574;
You have access
kappa-Opioid inhibition of [3H]dopamine release from rat ventral mesencephalic dissociated cell cultures.
J A Smith, S E Loughlin and F M Leslie

Molecular Pharmacology October 1992, 42 (4) 575-583;
You have access
Modulation of platelet-derived growth factor B mRNA abundance in macrophages by colchicine and dibutyryl-cAMP.
A Wangoo, A R Haynes, S P Sutcliffe, M Sorooshian and R J Shaw

Molecular Pharmacology October 1992, 42 (4) 584-589;
You have access
Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship.
P Fossé, B René, M Charra, C Paoletti and J M Saucier

Molecular Pharmacology October 1992, 42 (4) 590-595;
You have access
Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers.
D G Rhodes, R Newton, R Butler and L Herbette

Molecular Pharmacology October 1992, 42 (4) 596-602;
You have access
In vitro transformation of the human Ah receptor and its binding to a dioxin response element.
P A Harper, J V Giannone, A B Okey and M S Denison

Molecular Pharmacology October 1992, 42 (4) 603-612;
You have access
Mono- and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1).
K W Bock, H Gschaidmeier, A Seidel, S Baird and B Burchell

Molecular Pharmacology October 1992, 42 (4) 613-618;
You have access
[3H]noscapine binding sites in brain: relationship to indoleamines and the phosphoinositide and adenylyl cyclase messenger systems.
R J Mourey, T M Dawson, R K Barrow, A E Enna and S H Snyder

Molecular Pharmacology October 1992, 42 (4) 619-626;
You have access
Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
M S Choudhary, S Craigo and B L Roth

Molecular Pharmacology October 1992, 42 (4) 627-633;
You have access
Functional properties of the rat and human beta 3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells.
S B Liggett

Molecular Pharmacology October 1992, 42 (4) 634-637;
You have access
Two allosteric modulators interact at a common site on cardiac muscarinic receptors.
J Ellis and M Seidenberg

Molecular Pharmacology October 1992, 42 (4) 638-641;
You have access
Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy.
M C Michel, W Gaida, A G Beck-Sickinger, H A Wieland, H Doods, H Dürr, G Jung and G Schnorrenberg

Molecular Pharmacology October 1992, 42 (4) 642-648;
You have access
Influence of age on the beta 1- and beta 2-adrenergic receptors in rat liver.
A Van Ermen, E Van de Velde, P Vanscheeuwijck and N Fraeyman

Molecular Pharmacology October 1992, 42 (4) 649-655;
You have access
Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells.
S Gucker and J M Bidlack

Molecular Pharmacology October 1992, 42 (4) 656-665;
You have access
Characterization of the effects of a new Ca2+ channel activator, FPL 64176, in GH3 cells.
D L Kunze and D Rampe

Molecular Pharmacology October 1992, 42 (4) 666-670;
You have access
Chronic lithium treatment inhibits basal and agonist-stimulated responses in rat cerebral cortex and GH3 pituitary cells.
M A Varney, P P Godfrey, A H Drummond and S P Watson

Molecular Pharmacology October 1992, 42 (4) 671-678;
You have access
Effect of extracellular pH on the potency of N-methyl-D-aspartic acid receptor competitive antagonists.
M Benveniste and M L Mayer

Molecular Pharmacology October 1992, 42 (4) 679-686;
You have access
Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development.
J Barredo and R G Moran

Molecular Pharmacology October 1992, 42 (4) 687-694;
You have access
Regiochemical differences in cytochrome P450 isozymes responsible for the oxidation of methylenedioxyphenyl groups by rabbit liver.
Y Kumagai, L Y Lin, R M Philpot, H Yamada, K Oguri, H Yoshimura and A K Cho

Molecular Pharmacology October 1992, 42 (4) 695-702;
You have access
Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury.
R J Rothman, A Serroni and J L Farber

Molecular Pharmacology October 1992, 42 (4) 703-710;
You have access
Hypersensitivity to acetaldehyde-protein adducts.
Y Israel, A MacDonald, O Niemelä, D Zamel, E Shami, M Zywulko, F Klajner and C Borgono

Molecular Pharmacology October 1992, 42 (4) 711-717;
You have access
Correlations between the rate constant of singlet oxygen quenching by imidazole derivatives and anti-inflammatory activity in rats.
R V Bensasson, J Frederiksen, M Rougée, D Lexa and N Harrit

Molecular Pharmacology October 1992, 42 (4) 718-722;
You have access
In vivo evidence of hydroxyl radical formation after acute copper and ascorbic acid intake: electron spin resonance spin-trapping investigation.
M B Kadiiska, P M Hanna, L Hernandez and R P Mason

Molecular Pharmacology October 1992, 42 (4) 723-729;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals